Mercer Global Advisors »

Outlook Therapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $318 200 1.59

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Avan Us Smal Etf (AVSC)
Ishares Tr National Mun Etf (MUB)

View all positions for Mercer Global Advisors

Top funds holding Outlook Therapeutics

Vanguard Capital Management
Perceptive Advisors
Marshall Wace
Susquehanna International
BlackRock
Jane Street
Geode Capital Management
Hrt Financial
Vanguard Fiduciary Trust
Gilpin Wealth Management
Citadel Advisors
Sanctuary Advisors
Raymond James Financial
Group One Trading
Northern Trust

View all funds holding Outlook Therapeutics